Thiamine Hydrochloride Injection, Solution
Product Images NDC 70518-4230

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Thiamine Hydrochloride (NDC 70518-4230). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a prescription medication named Thiamine HCl in the form of 200mg/2mL injection vials manufactured by Hikma Pharma in Amman, Jordan. It is intended for intramuscular or intravenous use, with a quantity of 25 vials. The medication should be stored at 20-25°C (58-77°F) with excursions permitted to 15.30°C (59-86°F) and kept away from children. It is important to only use if the solution is clear and the seal is intact. The package insert includes detailed directions for use. And it is repackaged by Remedy Repacking, in PA, contact number 724.465.8762.*

FDA Label Image

Mm2 (Thiamine HCl 200mg 2ml(100mg mL) 70518 4230 01)

This text contains important information about the Thiamine HCl injection, including dosage, manufacturer, expiration date, sterile lot number, source NDC, and storage instructions. It is suitable for intramuscular or intravenous use and is a multiple-dose vial. The user should check the solution for clarity and intact seal before usage. The medication is to be kept out of reach of children and protected from light. For complete directions on usage, refer to the package insert. The product is manufactured by Hikma Pharma in Jordan.*

FDA Label Image

Structural Formula (Thiamine Hydrochloride Injection Usp 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.